• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Eli Lilly

Sidekick Health and Eli Lilly partner on digital therapeutics for breast cancer

June 17, 2022 By Sean Whooley

Sidekick Health today announced a collaboration on an integrated digital therapeutics solution in conjunction with Eli Lilly (NYSE:LLY). The collaboration between the companies will mark the first phase of a relationship between Sidekick and Lilly, which starts with a digital therapeutic offering for patients battling breast cancer. According to a news release, the first phase […]

Filed Under: Business/Financial News, Digital Health, Featured, Health Technology, Mammography, Oncology, Software / IT Tagged With: Eli Lilly, Sidekick Health

Glooko adds former Eli Lilly exec to its board of directors

April 27, 2022 By Sean Whooley

Diabetes management technology developer Glooko announced today that it appointed Alfonso “Chito” Zulueta to its board of directors. Zulueta joins Palo Alto, California-based Glooko’s board, having spent more than 30 years with Eli Lilly and Co., serving as a senior executive across an array of global business and commercial units. Get the full story at […]

Filed Under: Business/Financial News, Diabetes, Digital Health, Health Technology, Patient Monitoring, Software / IT Tagged With: Eli Lilly, Eli Lilly & Co., Glooko, Personnel Moves

10 leading pharma executives you need to know

April 25, 2022 By Brian Buntz

Given the complexity of the pharmaceutical business, it can be challenging to gauge the performance of any chief executive in the space. That said, CEOs’ annualized return over tenure as CEO over their term can hint at performance. In addition, rating sites like Glassdoor also indicate CEOs’ popularity. Here, we parsed a range of metrics, […]

Filed Under: Blog, Business/Financial News, Featured, News Well, Pharmaceutical Tagged With: AbbVie, Argenx, Eli Lilly, Evotec, Genmab, leadership, Novo Nordisk, Pfizer, Pharma 50, pharma execs, Sartorius Stedim Biotech, Thermo Fisher Scientific, West Pharmaceutical Services

Eli Lilly touts data for tirzepatide compared to insulin glargine for type 2 diabetes

October 21, 2021 By Sean Whooley

Eli Lilly (NYSE:LLY) announced positive results from a trial comparing tirzepatide to titrated insulin glargine in adults with type 2 diabetes. Indianapolis-based Eli Lilly’s Surpass-4 clinical trial demonstrated that adults with type 2 diabetes and increased cardiovascular (CV) risk experienced superior A1C and body weight reductions from baseline across all three doses of tirzepatide compared to […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Pharmaceutical Tagged With: Eli Lilly, Eli Lilly & Co.

Eli Lilly to donate nearly $1M to Type 1 diabetes initiative

September 7, 2021 By Sean Whooley

Eli Lilly (NYSE:LLY) announced today that it will commit nearly $1 million over the next three years toward helping children with type 1 diabetes. Indianapolis-based Eli Lilly, in a joint effort with the Leona M. and Harry B. Helmsley Charitable Trust, seeks to promote greater access to care and resources while inspiring confidence for children living […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Funding Roundup Tagged With: Eli Lilly, Eli Lilly & Co.

MedTech 100 roundup: On the rise again

August 23, 2021 By Sean Whooley

After a slight hiccup disrupted weeks of improvement, the medtech industry again flexed its muscles over the last seven days. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 20) at 119.63 points, representing a 1.5% rise from the 117.92-point tally set a week prior. […]

Filed Under: Business/Financial News, Featured, Funding Roundup, MassDevice Earnings Roundup, Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: Alcon, Eli Lilly, Grail, Illumina Inc., Johnson & Johnson, MedTech 100 Index, Personnel Moves, Ra Medical, stevanato group, Strata Skin Sciences, Stryker, Ultrahuman

Eli Lilly forms neuroscience and immunology units amid leadership changes

August 17, 2021 By Sean Whooley

Eli Lilly (NYSE:LLY) today announced executive leadership changes as it creates neuroscience and immunology business units. Indianapolis-based Eli Lilly split its bio-medicines segment into Lilly Neuroscience and Lilly Immunology in the organizational shift, to be made effective Sep. 5, with Anne White set to lead the neuroscience unit and Patrik Jonsson set to head up the […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pharmaceutical Tagged With: Eli Lilly, Eli Lilly & Co., Personnel Moves

FDA approves, expands label for Eli Lilly’s rapid-acting insulin for infusion

August 16, 2021 By Sean Whooley

Eli Lilly (NYSE:LLY) announced today that it received FDA approval and expanded labeling for its Lyumjev rapid-acting insulin. Indianapolis-based Eli Lilly’s Lyumjev (insulin lispro-aabc injection) 100 units/mL holds indication to improve glycemic control in adults with type 1 and type 2 diabetes, including administration via continuous subcutaneous insulin infusion (CSII) with an insulin pump. Get the […]

Filed Under: Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Eli Lilly, Eli Lilly & Co., FDA, insulin, insulin pump, Lyumjev

MedTech 100 roundup: Industry shatters all-time best with remarkable rise

July 19, 2021 By Sean Whooley

The medtech industry’s steady growth provided optimism in recent weeks, but an unforeseen leap sees it hitting new heights now. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (July 16) at 145.88 points, a remarkable 27.1% rise week-over-week, registering by far the greatest increase the […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: Bardy Diagnostics, BD, Eli Lilly, Eli Lilly & Co., HeartFlow, Hillrom, Imperative Care, MedTech 100 Index, Pfizer, Stryker

DoJ subpoenas Eli Lilly over bamlanivimab plant

May 28, 2021 By Brian Buntz

In an SEC filing, Eli Lilly (NYSE:LLY.N) revealed that it had received a subpoena from the U.S. Department of Justice connected to a manufacturing site in New Jersey that produces bamlanivimab, one of two COVID-19 monoclonal antibodies it produces. The plant also produces the blockbuster Trulicity and cancer drugs. Lilly did not state which types […]

Filed Under: Featured, Pharmaceutical Tagged With: bamlanivimab, Eli Lilly, Lilly, Trulicity

Pharma’s top 20 R&D spenders in 2020

May 13, 2021 By Brian Buntz

The past year has been an unprecedented time for the pharmaceutical industry. On the one hand, the pandemic resulted in substantial delays to clinical trials while also forcing sponsors to rethink clinical trial design to protect participants. But on the other hand, the pandemic underscored the importance of the pharma industry in society.  While the […]

Filed Under: Featured, Pharmaceutical, Research & Development Tagged With: AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Eisai, Eli Lilly, H. Lundbeck, Incyte, Janssen, Merck, Novartis, Otsuka Holdings, Pfizer, Regeneron Pharmaceuticals, Roche, Roche Group, Roche Pharmaceuticals, Sumitomo Danippon Pharma, UCB, Vertex Pharmaceuticals

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS